Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,798
Companies 1,771
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,798 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Recently updated

FDA-approved

Showing page 24 of 200 · By data quality, then INN

  1. lumacaftor

    ORKAMBI Vertex Pharmaceuticals (Australia) Pty.

    EMA: approved

    R07AX30

  2. lumasiran

    OXLUMO Lacuna Pharma Pty Ltd

    EMA: approved · TGA: approved

    A16AX18

  3. lumasiran sodium

    OXLUMO Alnylam Netherlands B.V.

    SUBCUTANEOUS FDA: approved

  4. lurasidone hydrochloride

    LATUDA Amneal Pharma Europe Ltd

    ORAL FDA: approved

  5. lurbinectedin

    ZEPZELCA Jazz Pharmaceuticals Ireland Limited

    INTRAVENOUS FDA: approved · EMA: unknown

    L01XX69

  6. magnesium sulfate

    MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER Amneal Pharma Europe Ltd

    IRRIGATION FDA: approved

  7. mannitol

    BRONCHITOL Milestone Pharmaceuticals

    IRRIGATION FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    R05CB16

  8. maprotiline hydrochloride

    MAPROTILINE HYDROCHLORIDE Beam Therapeutics

    ORAL FDA: approved

  9. maralixibat chloride

    LIVMARLI Mirum Pharmaceuticals International B.V.

    ORAL FDA: approved · EMA: approved · PMDA: approved

    A05AX04

  10. maribavir

    LIVTENCITY Lacuna Pharma Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    J05AX10

  11. mecasermin

    INCRELEX Lacuna Pharma Pty Ltd

    EMA: approved · TGA: approved

    H01AC03

  12. meclizine hydrochloride

    MECLIZINE HYDROCHLORIDE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  13. meclofenamate sodium

    MECLOFENAMATE SODIUM Quantum Biopharma

    ORAL FDA: approved

  14. medical air

    MEDICAL AIR, USP United Therapeutics Europe Ltd

    INHALATION FDA: approved

  15. medroxyprogesterone acetate

    MEDROXYPROGESTERONE ACETATE Amneal Pharma Europe Ltd

    INJECTION FDA: approved

  16. megestrol acetate

    MEGESTROL ACETATE Teva Pharma GmbH

    ORAL FDA: approved

  17. meloxicam

    APX-MELOXICAM Alphapharm Pty Ltd

    ORAL FDA: approved · TGA: approved

  18. memantine hydrochloride

    MEMANTINE MERZ Amneal Pharma Europe Ltd

    ORAL FDA: approved · EMA: approved · PMDA: approved

    N06DX01

  19. meprobamate

    MEPROBAMATE Teva Pharma GmbH

    ORAL FDA: approved

  20. mequinol

    SOLAGE Almirall, S.A.

    TOPICAL FDA: approved

  21. meropenem

    VABOREM Amneal Pharma Europe Ltd

    INJECTION FDA: approved · EMA: approved · NMPA: clinical trials

    J01DH

  22. mesalamine

    MESALAMINE Amneal Pharma Europe Ltd

    RECTAL FDA: approved

  23. mesna

    UROMITEXAN BAXTER HEALTHCARE PTY LTD

    ORAL FDA: approved · TGA: approved

  24. metaproterenol sulfate

    ALUPENT Aldeyra Therapeutics

    ORAL FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,798 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.